
"I saw a patient who's no longer a patient, and there's nothing better than that."
Where I see patients (1)
Selected research
-
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Blood
-
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia.
Nature communications
-
In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer.
bioRxiv : the preprint server for biology
Clinical trials
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or...
The response rate will be estimated using the proportion of eligible/evaluable patients with CR/CRi response. A one-sided lower 95% Agresti-Coull confidence limit will be calculated.
Recruiting
More about this studyContact me
Staff superheroes
It’s a bird. It’s a plane. It’s a window washer! Dressed as a superhero to clean and brighten your day.
